What Has Been the Progress and Growth of the Injectable Cement Market in Recent Years?
The injectable cement market has seen considerable growth due to a variety of factors.
• The injectable cement market has witnessed substantial growth in the past few years. The market is projected to expand from $1.45 $ billion in 2024 to $1.55 $ billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%.
Factors contributing to its growth during the historic period include the escalating cases of osteoporosis, increased frequency of bone fractures, surging demand for joint replacement surgeries, regulatory endorsements, and the introduction of new products into the market.
What Is The Expected Growth In The Injectable Cement Market Size Evolve over the Forecast Period?
The injectable cement market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for injectable cement is anticipated to witness robust growth in the coming years, ballooning to $2 $ billion in 2029 with a compound annual growth rate (CAGR) of 6.5%.
Factors driving the growth during the forecast period include a growing older population, rising worries about bone health, an expanded healthcare infrastructure, increased preference for outpatient treatment, and an escalating number of sports injuries. Key trends during this period are expected to include improved biocompatibility, innovation in antibiotic-loaded cement, less invasive application methods, bespoke patient solutions, and intelligent cement with tracking features.
What Main Forces Are Fueling Expansion In The Injectable Cement Market?
The surge in sports-related injuries is predicted to fuel the injectable cement market's expansion. These athletic injuries, including strains, sprains, fractures, and concussions, occur during sports activities and often necessitate medical treatment and rehabilitation for healing. The escalation in these injuries can be linked to a heightened participation in sports activities, rigorous training sessions, and improvements in sports equipment that challenge the body's boundaries, thereby causing an escalation in injury incidences among athletes across the globe. Injectable cement for these injuries plays a vital role in stabilizing fractures, promoting bone healing, and improving surgical results by offering a trustworthy and least invasive resolution for bone fortification. For instance, the National Safety Council, a US nonprofit organization focused on health and safety, reported a 20% rise in sports and recreational injuries in 2021, a 12% climb in 2022, and a 2% increment in 2023. Consequently, the upward trend in sports-related injuries is anticipated to accelerate the injectable cement market's growth.
What Are The Primary Segments In The Global Injectable Cement Market?
The injectable cementmarket covered in this report is segmented –
1) By Type: High Viscosity Cement, Low Viscosity Cement, Medium Viscosity Cement
2) By Application: Periprosthetic Fractures, Pelvic Fractures, Other Applications
3) By End User: Hospital, Clinics, Other End Users
Subsegments:
1) By High Viscosity Cement: Calcium Phosphate Cements, PMMA (Polymethyl Methacrylate) Cements
2) By Low Viscosity Cement: Acrylic-Based Injectable Cements, Bioactive Glass Cements
3) By Medium Viscosity Cement: Hybrid Injectable Cements, Composite Injectable Cements
Pre-Book The Injectable Cement Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Reshaping The Future Of The Injectable Cement Market?
Injectable cement market leaders are currently leaning towards technological innovation, such as antibiotic-loaded bone cement, in their quest to bolster infection control, optimize patient results, and facilitate more efficient, targeted treatment during orthopedic surgery. This kind of bone cement, which contains antibiotics incorporated directly into the cement, is designed to protect against or treat surgical site infections, particularly in orthopedic procedures. An example of this is COPAL G+C, a new antibiotic-loaded bone cement developed by Heraeus Medical GmbH, a medical technology company based in Germany, which was unveiled in April 2024. This is the firm's first product to gain certification under the MDR. COPAL G+C integrates two antibiotics, gentamicin and clindamycin, directly into the bone cement, thereby providing targeted infection control in arthroplasty by tackling up to 90% of the pathogens frequently encountered in prosthetic joint infections.
Who Are the Key Players In The Injectable Cement Market?
Major companies operating in the injectable cement market are:
• Johnson & Johnson
• 3M Company
• Medtronic Plc.
• Stryker Corporation
• B. Braun Melsungen AG
• Zimmer Biomet Holdings Inc.
• Smith & Nephew
• Arthrex Inc.
• Cook Medical LLC
• Enovis Corporation
• Globus Medical Inc.
• Wright Medical Group N.V
• Medacta International
• Orthofix Medical Inc.
• Alphatec Spine Inc. (ATEC Spine)
• Exactech Inc.
• Spine Wave Inc.
• Tecres SpA
• Somatex Medical Technologies
• Heraeus Medical GmbH
• DJO Global Inc.
• TEKNIMED
• G-21
• Kyeron Medical Innovations
• Graftys SA
What Is The Most Dominant Region In The Injectable Cement Market?
North America was the largest region in the injectable cement market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
